Multimodal intervention raises smoking cessation rate during pregnancy.

What Was Tested

Researchers studied Nicotine in this randomized controlled trial publication.

The aim was to study the effect of a multimodal smoking cessation intervention regimen on a number of pregnant smokers.

Who Took Part

By PubMed's age tags, the people studied were adults, women only.

A prospective intervention study was designed where participants were allocated to intervention or control based on their birth date.

The intervention group (n = 327) received initial individual smoking cessation counseling supplemented by an invitation to join, individually or in a group, a smoking cessation program with nicotine replacement therapy as a voluntary option.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Nicotine and who got the comparison, which limits bias.

The study included 647 pregnant smokers.

Intervention was designed as an integral part of the midwives' prenatal care.

All pregnant smokers in the usual care group (n = 320) received standard counseling from a midwife.

Outcome was self-reported smoking cessation in the 37th week of pregnancy and the reported cessation was validated by cotinine saliva concentration.

What Was Measured

Topics PubMed links to this paper include Cotinine, Counseling, Nicotine, Odds Ratio, Pregnancy Complications, Prenatal Care and Saliva.

What This Means in Plain Language

The paper is a randomized study of Nicotine.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2003 (Acta obstetricia et gynecologica Scandinavica), a journal based in United States.

More context: the related Therapeutic nicotine (patch, non-peptide) library page, all human trials.